Fast recovery with etanercept in patients affected by polymyalgia rheumatica and decompensated diabetes : a case-series study

We enrolled nine consecutive patients affected by newly diagnosed polymyalgia rheumatica and decompensated diabetes mellitus. All patients were treated with etanercept (25 mg twice weekly) and prednisone and were followed up to 1 year. At the sixth-month follow-up, etanercept and prednisone were withdrawn. Patients were seen at regular intervals (days 0, 30, 60, 90, 150, 180) and the following variables determined: erythrocytes sedimentation rate, C-reactive protein, fasting serum glucose, pain measured by visual analog scale, and the Health Assessment Questionnaire. Our results indicate that etanercept might have some steroid-sparing effects, but controlled investigations are needed to support etanercept use in clinical practice for this kind of patients.

Medienart:

E-Artikel

Erscheinungsjahr:

2009

Erschienen:

2009

Enthalten in:

Zur Gesamtaufnahme - volume:28

Enthalten in:

Clinical rheumatology - 28(2009), 1 vom: 19. Jan., Seite 89-92

Sprache:

Englisch

Beteiligte Personen:

Corrao, Salvatore [VerfasserIn]
Pistone, Giovanni [VerfasserIn]
Scaglione, Rosario [VerfasserIn]
Colomba, Daniela [VerfasserIn]
Calvo, Luigi [VerfasserIn]
Licata, Giuseppe [VerfasserIn]

Links:

Volltext

Themen:

Antirheumatic Agents
Etanercept
Hypoglycemic Agents
Immunoglobulin G
Insulin
Journal Article
OP401G7OJC
Prednisone
Receptors, Tumor Necrosis Factor
VB0R961HZT

Anmerkungen:

Date Completed 26.02.2009

Date Revised 13.11.2018

published: Print-Electronic

Citation Status MEDLINE

doi:

10.1007/s10067-008-1026-6

funding:

Förderinstitution / Projekttitel:

PPN (Katalog-ID):

NLM183922786